Evidence mapPaperPMID 42390843Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Pathological Copper Overload Reprograms SOD1 Activation via COMMD1 to Promote Senescence and Fibrosis.

Yuqing Liu, Jing Liu, Wenqian Zhou, Yangyang Niu, Yan Zheng, Yiguo Liu, Yingying Zhang, Chen Yu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuqing LiuDepartment of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Jing LiuDepartment of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Wenqian ZhouDepartment of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Yangyang NiuDepartment of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Yan ZhengDepartment of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Yiguo LiuDepartment of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Yingying ZhangDepartment of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Chen YuDepartment of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

Funding

Key Supported Discipline of Health System in Shanghai 2023ZDFC0302National Natural Science Foundation of China 82470764National Natural Science Foundation of China U25A2032Science and Technology Innovation Plan Of Shanghai Science and Technology Commission 23Y11908900
6 · The paper itself

Abstract

Superoxide dismutase 1 (SOD1), a copper-dependent antioxidant, is essential for redox homeostasis, and its decline drives renal senescence and fibrosis. However, the mechanisms linking profibrotic signaling to SOD1 inhibition remain unclear. Here, we identified a pathological copper-COMMD1-SOD1 axis in which intracellular copper overload paradoxically suppressed SOD1 activity. In kidney tissues from chronic kidney disease (CKD) patients and complementary in vivo and in vitro fibrotic models, we consistently observed a reduction in SOD1 activity accompanied by elevated intracellular copper levels. Lowering intracellular copper levels restored SOD1 activity, suppressed reactive oxygen species (ROS) accumulation, and alleviated cell senescence and fibrosis. Mechanistically, pathological copper overload impaired SOD1 homodimerization, the essential final step in its activation. We identified copper metabolism MURR1 domain containing 1 (COMMD1) as a key copper-sensitive mediator of this process. Copper overload acted upstream, simultaneously upregulating COMMD1 expression and enhancing its binding affinity to SOD1. This enhanced COMMD1-SOD1 interaction directly disrupted SOD1 homodimer assembly and enzymatic function. Collectively, these findings redefined the regulatory role of copper in SOD1 activity and uncovered a previously unrecognized mechanism by which pathological copper overload paradoxically suppressed SOD1 activity via COMMD1-dependent disruption of SOD1 homodimerization, providing new insight into the pathophysiology of copper dyshomeostasis-associated diseases.

Indexed as

cellular senescencecopper homeostasiscopper metabolism MURR1 domain containing 1 (COMMD1)renal fibrosissuperoxide dismutase 1 (SOD1)

Identifiers

PMID42390843
PMCPMC13334582

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.